3rd Quarter - Amendment

BAXTER HEALTHCARE CORPORATION for BAXTER HEALTHCARE CORPORATION

Firm
Client
Income
—
Expenses
$470,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
3rd Quarter - Report Oct 19, 2021 $430,000 Replaced
3rd Quarter - Amendment (this page) Oct 20, 2021 $470,000 Yes

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Taxation of multinational companies. Monitor tax reform proposal relating to corporate tax policies.

LobbyistCovered position, as disclosed
CADE CLURMAN —
JOSEPH V SCHWAN —

Contacted: HOUSE OF REPRESENTATIVES; Homeland Security, Dept of (DHS); SENATE; Health & Human Services, Dept of (HHS)

Health Issues HCR

Issues relating to drug pricing, home dialysis expansion, ESRD reimbursement for Hemodialysis, 340B Drug pricing, device sterilization, MDUFA reauthorization.

LobbyistCovered position, as disclosed
CADE CLURMAN —
MARK COIN —
CHRISTOPHER LEIBUNDGUTH —
JACK MANIKO —
CHRISTOPHER NASO New Staff Assistant to Rep. Mike McIntyre in 2012 Staff Assistant and Legislative Correspondent for Rep. Michelle Lujan Grisham 2013-15
JOSEPH V SCHWAN —

Contacted: Homeland Security, Dept of (DHS); SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Veterans VET

Veterans patient quality improvement. FY2022 MilConVA appropriations.

LobbyistCovered position, as disclosed
CADE CLURMAN —
MARK COIN —
CHRISTOPHER NASO New Staff Assistant to Rep. Mike McIntyre in 2012 Staff Assistant and Legislative Correspondent for Rep. Michelle Lujan Grisham 2013-15

Contacted: Homeland Security, Dept of (DHS); SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

HR3, Elijah E. Cummings Lower Drug Costs Now Act, all provisions. HR19 / S. 2164, Lower Costs, More Cures Act of 2021, all provisions. Legislation to incentivize new technology for innovation in home dialysis (no current bill number). S.2025, Patient Access to ESRD New Innovative Devices Act, all provisions.

LobbyistCovered position, as disclosed
CADE CLURMAN —
MARK COIN —
CHRISTOPHER LEIBUNDGUTH —
JACK MANIKO —
CHRISTOPHER NASO New Staff Assistant to Rep. Mike McIntyre in 2012, Staff Assistant and Legislative Correspondent for Rep. Michelle Lujan Grisham 2013-15.
JOSEPH V SCHWAN —

Contacted: SENATE; Homeland Security, Dept of (DHS); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Bills named: H.R. 19 (117th), H.R. 3 (117th), S. 2164 (117th), S. 2025 (117th)

Budget/Appropriations BUD

Issues related to increasing funding for Strategic National Stockpile.

LobbyistCovered position, as disclosed
JACK MANIKO —
JOSEPH V SCHWAN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Homeland Security, Dept of (DHS)

Homeland Security HOM

Issues related to allocation and access to Baxter products during the COVID-19 emergency declaration.

LobbyistCovered position, as disclosed
CADE CLURMAN —
MARK COIN —
CHRISTOPHER LEIBUNDGUTH —
JACK MANIKO —
JOSEPH V SCHWAN —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Homeland Security, Dept of (DHS); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.